Medicare Enrolled
Dr. Pankaj Satija, M.D.
Brain Injury Medicine (Psychiatry & Neurology) Physician · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Satija from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Satija?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Satija
Dr. Pankaj Satija is a brain injury medicine physician in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Satija performed 7,679 Medicare services across 1,219 unique beneficiaries.
Between the years covered by Open Payments, Dr. Satija received a total of $1,079,338 from 84 pharmaceutical and/or device companies across 2232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in brain injury medicine (psychiatry & neurology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Satija is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 50% volume in TX
$1,079,338 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,679
Medicare services
Top 50% in TX for brain injury medicine (psychiatry & neurology) physician
1,219
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~452 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
2,611 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,285 | $0 | $10 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
565 | $0 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
387 | $99 | $465 |
| Injection, methylprednisolone acetate, 40 mg | 301 | $6 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
215 | $66 | $394 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
211 | $40 | $633 |
| Compounded drug, not otherwise classified A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products. |
160 | $94 | $1,042 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
146 | $5 | $15 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
137 | $75 | $399 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
136 | $47 | $228 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
134 | $12 | $30 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
50 | $266 | $1,651 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
43 | $292 | $924 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
36 | $91 | $312 |
| New patient office visit, complex (60-74 min) | 34 | $166 | $804 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
32 | $4 | $500 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
31 | $530 | $1,659 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
28 | $118 | $636 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 25 | $42 | $722 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
24 | $205 | $1,300 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
23 | $110 | $680 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $65 | $767 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
16 | $223 | $1,185 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
16 | $113 | $659 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
12 | $201 | $1,102 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$1,079,338
Total received (2018-2024)
Avg $154,191/year across 7 years
Top 33% in TX for brain injury medicine (psychiatry & neurology) physician
84
Companies
2,232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,053,478 (97.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,526 (2.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,334 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$130,342
2023
$121,702
2022
$212,137
2021
$186,278
2020
$100,317
2019
$136,291
2018
$192,272
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$259,302
Amgen Inc.
$253,040
AbbVie Inc.
$177,780
Biohaven Pharmaceutical Holding Company Ltd.
$76,164
Daiichi Sankyo Inc.
$65,870
Teva Pharmaceuticals USA, Inc.
$56,042
Biohaven Pharmaceuticals, Inc.
$52,453
Lilly USA, LLC
$51,300
Allergan, Inc.
$25,734
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18,929
Supernus Pharmaceuticals, Inc.
$8,787
AstraZeneca Pharmaceuticals LP
$5,575
PFIZER INC.
$5,224
Abbott Laboratories
$3,527
Medtronic, Inc.
$3,231
Medtronic USA, Inc.
$2,662
Lundbeck LLC
$2,146
Novartis Pharmaceuticals Corporation
$1,296
UCB, Inc.
$814
Vertiflex, Inc.
$805
Nevro Corp.
$525
Merz North America, Inc.
$482
Medtronic Vascular, Inc.
$461
Merz Pharmaceuticals, LLC
$423
Takeda Pharmaceuticals U.S.A., Inc.
$357
Genesys Orthopedics Systems, L.L.C.
$352
Nuvectra Corporation
$339
Inspire Medical Systems, Inc.
$328
Biogen, Inc.
$311
Collegium Pharmaceutical, Inc.
$299
Allergan Inc.
$265
MERZ NORTH AMERICA, INC.
$231
SK Life Science, Inc.
$225
BOSTON SCIENTIFIC CORPORATION
$221
Grifols USA, LLC
$216
Upsher-Smith Laboratories LLC
$207
AQUESTIVE THERAPEUTICS, INC.
$197
IDORSIA PHARMACEUTICALS US INC
$194
GRT US Holding, Inc.
$178
ARBOR PHARMACEUTICALS, INC.
$166
TerSera Therapeutics LLC
$161
JAZZ PHARMACEUTICALS INC.
$160
Eisai Inc.
$157
SI-BONE, Inc.
$154
Boston Scientific Corporation
$116
Jazz Pharmaceuticals Inc.
$114
LivaNova USA, Inc.
$111
Promius Pharma LLC
$109
Azurity Pharmaceuticals, Inc.
$98
Scilex Pharmaceuticals Inc.
$93
CATALYST PHARMACEUTICALS, INC.
$91
EISAI INC.
$81
UPSHER-SMITH LABORATORIES LLC
$76
SCILEX PHARMACEUTICALS INC.
$71
Saluda Medical Americas, Inc.
$71
Sunovion Pharmaceuticals Inc.
$71
FUJIFILM SonoSite, Inc.
$66
Bausch Health US, LLC
$63
Horizon Therapeutics plc
$60
Stimwave Technologies Incorporated
$60
US WorldMeds, LLC
$53
Arbor Pharmaceuticals, Inc.
$51
Vertos Medical, Inc.
$50
Pernix Therapeutics Holdings, Inc.
$45
BIOTRONIK NRO, Inc.
$44
Avanir Pharmaceuticals, Inc.
$38
Vertical Pharmaceuticals, LLC
$38
Shionogi Inc
$37
DePuy Synthes Sales Inc.
$28
Purdue Pharma L.P.
$27
Egalet US Inc
$26
RedHill Biopharma Inc.
$26
BioDelivery Sciences International, Inc.
$25
Assertio Therapeutics, Inc.
$25
Horizon Pharma plc
$24
Amneal Pharmaceuticals LLC
$24
Innovation Technologies Inc
$22
Aziyo Biologics, Inc.
$22
Zyla Life Sciences
$21
Zyla Life Sciences, Inc.
$20
Almatica Pharma LLC
$16
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
IBSA Pharma Inc.
$12
Sentynl Therapeutics, Inc.
$11
Top 3 companies account for 63.9% of total payments
Associated products mentioned in payments ›
ADAPTIVESTIM · ADUHELM · AIMOVIG · AJOVY · AMYVID · APTIOM · ARYMO ER · AUTOFILL · AVONEX · Aimovig · Algovita · Amitiza · Axium Sheath Braided DRG · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL 2.1 mg 30-count box · Briviact · CAMBIA · Cambia · ClosureFast · DUEXIS · Dayvigo · ECM Patch · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Edarbi · Edarbyclor · Evoke SCS · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GRALISE · Gamunex-C · General - Pain Management · HORIZANT · HYQVIA · Horizant · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · KESIMPTA · KISUNLA · KYPHON Balloon Kyphoplasty · LORZONE · LUCEMYRA · LYRICA · Levorphanol · Licart · Lucemyra · Lucemyra/Lofexidine · MIGRANAL · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NUEDEXTA · NURTEC ODT · Nayzilam · Nucynta · Nuedexta · ORTHOVISC · OXTELLAR XR · Omnia · PENNSAID · PRIALT · PROCLAIM · Pouch · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prospera · Protege Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · Qutenza · RELEXXII · RELISTOR · RELISTOR ORAL · RESTORE · REYVOW · RoxyBond · S Series Ultrasound System · SACROILIAC JOINT FUSION SYSTEM · SPECTRA WAVEWRITER · SPINRAZA · SPRIX · SYMPAZAN · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · Superion Indirect Decompression System · Symproic · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · UBRELVY · V-LOC 180 · VIGADRONE (vigabatrin) for Oral Solution · VNS - Symmetry · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VYEPTI · WAVEWRITER ALPHA · XCOPRI · XEOMIN · XTAMPZA · Xeomin · Xtampza ER · ZEMBRACE SYMTOUCH · ZOHYDRO ER · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zembrace SymTouch Sumatriptan Injection · mild Device Kit · movantik
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in brain injury medicine (psychiatry & neurology) physician and does not inherently indicate bias, but patients may wish to be aware.
Equivalent to $14,056 per 100 Medicare services performed
Geographic Context
Brain injury medicine physicians within 10 mi
2
Per 100K population
0.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Satija is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Satija experienced with midazolam injection, per 1 mg?
Based on Medicare claims data, Dr. Satija performed 2,611 midazolam injection, per 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Satija receive payments from pharmaceutical companies?
Yes. Dr. Satija received a total of $1,079,338 from 84 companies across 2,232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Satija's costs compare to other brain injury medicine physicians in Houston?
Dr. Satija's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Satija) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Brain Injury Medicine Physicians in Houston
Browse brain injury medicine physicians in Houston ranked by procedure volume and transparency data.
Highest volume
Top Brain Injury Medicine Physicians in TX
Brain injury medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Brain Injury Medicine Physicians in TX
Which TX brain injury medicine physicians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology